Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Topical treatment of basal cell carcinoma with the immune response modifier imiquimod
Dimitrios Papakostas, Eggert Stockfleth
Future Oncology (2015) Vol. 11, Iss. 22, pp. 2985-2990
Closed Access | Times Cited: 22

Showing 22 citing articles:

Inflammation: A key process in skin tumorigenesis (Review)
Monica Neagu, Carolina Constantin, Constantin Căruntu, et al.
Oncology Letters (2018)
Open Access | Times Cited: 117
Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19
Athina Angelopoulou, Nikolaos Alexandris, Evangelia Konstantinou, et al.
Environmental Research (2020) Vol. 188, pp. 109858-109858
Open Access | Times Cited: 81
Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications
Sandra Grund‐Gröschke, Georg Stockmaier, Fritz Aberger
Cell Communication and Signaling (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 64
Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists
Carole Bourquin, Aurélien Pommier, C. Hotz
Pharmacological Research (2019) Vol. 154, pp. 104192-104192
Open Access | Times Cited: 57
Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation
Jérôme Widmer, Cédric Thauvin, Inès Mottas, et al.
International Journal of Pharmaceutics (2017) Vol. 535, Iss. 1-2, pp. 444-451
Open Access | Times Cited: 53
Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities
N.J. Collier, Lesley E. Rhodes
Molecules (2020) Vol. 25, Iss. 22, pp. 5398-5398
Open Access | Times Cited: 38
Multidimensional applications of prussian blue-based nanoparticles in cancer immunotherapy
Jiayi Zhang, Fang Wang, Zhaogang Sun, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica
Rana El Hajj, Hanady Bou Youness, Laurence Lachaud, et al.
PLoS neglected tropical diseases (2018) Vol. 12, Iss. 11, pp. e0006854-e0006854
Open Access | Times Cited: 32
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments
Cristina Pellegrini, Augusto Orlandi, Gaetana Costanza, et al.
PLoS ONE (2017) Vol. 12, Iss. 8, pp. e0183415-e0183415
Open Access | Times Cited: 32
2-Azidobenzaldehyde-Based [4+2] Annulation for the Synthesis of Quinoline Derivatives
Xiaofeng Zhang, Miao Liu, Weiqi Qiu, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1241-1241
Open Access | Times Cited: 1
Huang Lian Jie Du Decoction enhances the anti-tumor efficacy of immune checkpoint inhibitors by activating TLR7/8 signalling in melanoma
Suqing Liu, Yaohua Zhang, Xiaohua Zhu, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Soluble Factors and Receptors Involved in Skin Innate Immunity—What Do We Know So Far?
Lucian G. Scurtu, Olga Simionescu
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1795-1795
Open Access | Times Cited: 7
From Local to Systemic Treatment: Leveraging Antitumor Immunity Following Irreversible Electroporation
Anita G.M. Stam, Tanja D. de Gruijl
Springer eBooks (2017), pp. 249-270
Closed Access | Times Cited: 6
Skin field cancerisation: A systematic review of the literature regarding its treatment
Fernando Antônio Gomes de Andrade, Felipe Contoli Isoldi, Lydia Masako Ferreira
European Journal of Cancer Care (2020) Vol. 30, Iss. 2
Open Access | Times Cited: 4
Contemporary approaches to basal cell carcinoma diagnosis and treatment
Xinyuan Wu, Ashfaq A. Marghoob
Future Oncology (2015) Vol. 11, Iss. 22, pp. 2965-2966
Closed Access | Times Cited: 2
Development of CXCR4 Inhibitors for Topical Treatment of Psoriasis
Suthida Boonsith
(2017)
Closed Access | Times Cited: 1
Enhancement of interferon treatment for large basaliomas
В. А. Молочков, S. A. Rumyantsev, А. Н. Хлебникова
Almanac of Clinical Medicine (2017) Vol. 45, Iss. 4, pp. 314-320
Open Access | Times Cited: 1
Basal Cell Carcinoma
Elise Ng, Joanna Dong, Désirée Ratner
Springer eBooks (2019), pp. 723-748
Closed Access | Times Cited: 1
Cutaneous Malignancies in the Immunocompromised Patient
Walmar Roncalli Pereira de Oliveira, Marcela Soares Pincelli, Isadora Zago Miotto, et al.
Springer eBooks (2023), pp. 587-619
Closed Access
Cells to Surgery Quiz: March 2017
Jessica Cervantes, Sebastian H. Verne, Robert J. Magno, et al.
Journal of Investigative Dermatology (2017) Vol. 137, Iss. 3, pp. e29-e29
Open Access
Faculty Opinions recommendation of EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica.
Roberto Arenas, Eder Rodrigo Juárez-Durán
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature (2020)
Open Access
Systematic Review of Management of Superficial Basal Cell Carcinoma
A Mandal, Shubhi Gupta, M Bharadwaj
SAS Journal of Medicine (2022) Vol. 10, Iss. 7, pp. 489-495
Open Access
Page 1

Scroll to top